BioCentury | Sep 5, 2005
Clinical News

ACP-SL017: Phase I start

...with and without photoactivation. The company expects to complete the trial before the year end. Altachem Pharma Ltd....
BioCentury | Jan 3, 2005
Company News

Altachem management update

Altachem Pharma Ltd. (CDNX:AAF), Edmonton, Alberta Business: Infectious, Cancer Resigned: Warren Jackson as EVP of international business WIR Staff cancer Infectious...
BioCentury | Dec 20, 2004
Company News

Altachem board of directors update

Altachem Pharma Ltd. (TSE:AAF), Edmonton, Alberta Business: Infectious, Cancer Resigned: Robert Sydenham and Warren Jackson Appointed: Ragupathy Madiyalakan, a director, as chairman WIR Staff...
BioCentury | Aug 9, 2004
Company News

Isotechnika Inc., Altachem deal

...produced. AAF had been ISA's exclusive manufacturer for breath-based diagnostics. Isotechnika Inc. (TSE:ISA), Edmonton, Alberta Altachem Pharma Ltd....
BioCentury | Jan 6, 2003
Company News

Altachem management update

Altachem Pharma Ltd. (TSE:AAF), Edmonton, Alberta Business: Infectious diseases, Cancer Resigned: Madi Madiyalakan as EVP of R&D WIR Staff cancer Infectious...
BioCentury | Jan 6, 2003
Company News

Altachem board of directors update

Altachem Pharma Ltd. (TSE:AAF), Edmonton, Alberta Business: Infectious diseases, Cancer Resigned: Madi Madiyalakan WIR Staff cancer Infectious...
BioCentury | Apr 1, 2002
Clinical News

Altachem preclinical data

...human leukemia in culture. Data were presented at the Symposium on Sonodynamic Therapy in Fukuoka. Altachem Pharma Ltd....
BioCentury | Mar 25, 2002
Company News

Altachem deal

...to use the preclinical product alone and in combination with its hypocrellins to treat cancer. Altachem Pharma Ltd....
BioCentury | Apr 19, 1999
Company News

Steroidogenesis Inhibitors International, Altachem-Pharma Ltd. deal

...has received to $300,000 (see BioCentury, April 12). Steroidogenesis Inhibitors International (STGI), Las Vegas, Nev. Altachem-Pharma...
BioCentury | Apr 12, 1999
Clinical News

Anticort procaine: Began Phase I testing

...category: Immune stimulation Target: Cortisol Description: Procaine anti-cortisol immune booster Indication: Treat HIV infection/AIDS Status: Altachem Pharma Ltd....
Items per page:
1 - 10 of 10
BioCentury | Sep 5, 2005
Clinical News

ACP-SL017: Phase I start

...with and without photoactivation. The company expects to complete the trial before the year end. Altachem Pharma Ltd....
BioCentury | Jan 3, 2005
Company News

Altachem management update

Altachem Pharma Ltd. (CDNX:AAF), Edmonton, Alberta Business: Infectious, Cancer Resigned: Warren Jackson as EVP of international business WIR Staff cancer Infectious...
BioCentury | Dec 20, 2004
Company News

Altachem board of directors update

Altachem Pharma Ltd. (TSE:AAF), Edmonton, Alberta Business: Infectious, Cancer Resigned: Robert Sydenham and Warren Jackson Appointed: Ragupathy Madiyalakan, a director, as chairman WIR Staff...
BioCentury | Aug 9, 2004
Company News

Isotechnika Inc., Altachem deal

...produced. AAF had been ISA's exclusive manufacturer for breath-based diagnostics. Isotechnika Inc. (TSE:ISA), Edmonton, Alberta Altachem Pharma Ltd....
BioCentury | Jan 6, 2003
Company News

Altachem management update

Altachem Pharma Ltd. (TSE:AAF), Edmonton, Alberta Business: Infectious diseases, Cancer Resigned: Madi Madiyalakan as EVP of R&D WIR Staff cancer Infectious...
BioCentury | Jan 6, 2003
Company News

Altachem board of directors update

Altachem Pharma Ltd. (TSE:AAF), Edmonton, Alberta Business: Infectious diseases, Cancer Resigned: Madi Madiyalakan WIR Staff cancer Infectious...
BioCentury | Apr 1, 2002
Clinical News

Altachem preclinical data

...human leukemia in culture. Data were presented at the Symposium on Sonodynamic Therapy in Fukuoka. Altachem Pharma Ltd....
BioCentury | Mar 25, 2002
Company News

Altachem deal

...to use the preclinical product alone and in combination with its hypocrellins to treat cancer. Altachem Pharma Ltd....
BioCentury | Apr 19, 1999
Company News

Steroidogenesis Inhibitors International, Altachem-Pharma Ltd. deal

...has received to $300,000 (see BioCentury, April 12). Steroidogenesis Inhibitors International (STGI), Las Vegas, Nev. Altachem-Pharma...
BioCentury | Apr 12, 1999
Clinical News

Anticort procaine: Began Phase I testing

...category: Immune stimulation Target: Cortisol Description: Procaine anti-cortisol immune booster Indication: Treat HIV infection/AIDS Status: Altachem Pharma Ltd....
Items per page:
1 - 10 of 10